---

$4.50

+0.0650 ( -0.11% ) 495.3K

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-12-23	Buy	23529.00	Landman David
2024-12-12	Buy	30000.00	Beattie John Gregory
2024-12-10	Buy	100000.00	Landman David
2024-12-10	Buy	10000.00	Harrington Michael J
2024-12-10	Buy	7500.00	Brown Nigel
2024-08-14	Sale	-20000.00	Beattie John Gregory
2024-08-14	Sale	-27500.00	Coelho Mary Theresa
2024-08-14	Sale	-20000.00	Freeman Jeffrey Brennan
2024-08-14	Sale	-20000.00	Sagartz John E
2024-08-14	Sale	-20000.00	Taylor Beth

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.